Want to see DE:HNL full AI Analyst Report?
HNL Stock Chart & Stats
€7.96
-€0.10(-1.26%)
At close: 4:00 PM EDT
€7.96
-€0.10(-1.26%)
Day’s Range― - ―
52-Week Range€6.48 - €10.40
Previous CloseN/A
Volume1.49K
Average Volume (3M)6.13K
Market Cap
€49.59M
Enterprise Value€91.43
Total Cash (Recent Filing)€7.23M
Total Debt (Recent Filing)€46.62M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Dec 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding6,062,930
10 Day Avg. Volume3,193
30 Day Avg. Volume6,130
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.65
Price to Sales (P/S)0.53
P/FCF Ratio15.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.2
Revenue Forecast (FY)€93.60M
Bulls Say, Bears Say
Bulls Say
TTM Revenue ReboundThe sharp TTM revenue rebound indicates renewed demand for the company’s UV and LED industrial solutions. If sustained across end markets, higher sales can improve operating leverage and support a broader recovery in profitability.
Positive Cash GenerationPositive operating and free cash flow provides internal funding for operations, product development and customer support. This reduces reliance on external financing, although the durability of cash generation still depends on improving earnings quality.
Manageable LeverageModerate leverage and a substantial equity base provide financial flexibility during the turnaround. The balance sheet does not appear distressed, giving management capacity to invest in UV/LED systems and withstand uneven industrial demand.
Bears Say
Severe Gross Margin PressureThe collapse in gross margin shows that higher revenue has not translated into equivalent economic value. Unless pricing, product mix or production efficiency improves, weak gross profitability will constrain operating leverage and sustainable earnings.
Persistent UnprofitabilityOngoing losses and negative returns on equity indicate that the revenue recovery has not yet produced a durable business-level return. Continued unprofitability can restrict reinvestment capacity and weaken shareholder value creation over time.
Volatile Cash ConversionRecent positive cash flow is encouraging, but the history of weak or negative cash generation suggests limited consistency. Volatile conversion makes planning and funding investment more difficult until profitability and working-capital performance normalize.
Dr. Hoenle AG News
HNL FAQ
What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest stock price was €6.48 and its highest was €10.40 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €49.59M.
When is Dr. Hoenle AG’s upcoming earnings report date?
Dr. Hoenle AG’s upcoming earnings report date is Dec 08, 2026 which is in 107 days.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on Aug 18, 2026. The company reported -€0.037 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Dr. Hoenle AG overvalued?
According to Wall Street analysts Dr. Hoenle AG’s price is currently Overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of -€0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.259%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in DE:HNL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Hoenle AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.44%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.48%
Trailing 12-Months
Company Description
Dr. Hoenle AG
Dr. Hönle AG is a global provider specializing in industrial ultraviolet (UV) technologies and related systems, with operations spanning Germany and international markets. The company organizes its business into three main segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives division develops industrial bonding solutions for critical applications within sectors such as consumer electronics, medical technology, optics and opto-electronics, the automotive industry, and glass processing. Its Equipment & Systems segment focuses on developing solutions for the efficient drying of inks and coatings, the precise curing of adhesives and plastics, comprehensive surface disinfection, and advanced solar simulation. Lastly, the Glass & Lamps division manufactures quartz glass tubing and rods, which are vital for the lamp, automotive, semiconductor, and fiber optic cable industries, alongside producing specialized lamps utilized for water purification and the drying of various coatings and adhesives. Founded in 1976, Dr. Hönle AG is headquartered in Munich, Germany.
Technical Analysis
LPKF Laser & Electronics
―
Manz AG
―
MAX Automation
―
Singulus Technologies
―
Suss Microtec
―